Ireland's trade surplus experienced a significant increase in February 2025, reaching €12.8 billion, a substantial rise from €5.7 billion in the same month of the previous year. Export activity saw a remarkable 54.3% growth year-on-year, totaling EUR 24.6 billion. This surge was largely driven by a substantial increase in medical and pharmaceutical product sales, which climbed by 145.7% to EUR 15.6 billion and constituted 63.2% of all exports. The primary recipients of these exports were the United States, accounting for 52.5% of the total, followed by the Netherlands at 7.7% and Germany at 6.2%. Conversely, imports rose by a more moderate 14.5% to EUR 11.8 billion, primarily fueled by increased purchases of medical and pharmaceutical products, which rose by 84.2% to EUR 2 billion, encompassing 17.2% of total imports. Imports from the United States increased by 18.4%, making up 39.7% of total inbound trade.